Skip to main content
Erschienen in:

15.01.2024 | Research

Presentation and outcomes of paediatric craniopharyngioma in the west of Scotland: a 25 year experience

verfasst von: Xuan Ye Chanel Kuah, Angela K. Lucas-Herald, Sarah McCarrison, Roisin Boyle, Claire Adey, Anthony Amato-Watkins, Parameswaran Bhattathiri, Emer Campbell, Fiona Cowie, Liam Dorris, Ben Fulton, Diana Mcintosh, Dermot Murphy, Milind Ronghe, Roddy O’Kane, Lorraine Todd, Meharpal Sangra, Jairam Sastry, Eoghan Millar, Samih Hassan, M. Guftar Shaikh

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Craniopharyngiomas can be aggressive leading to significant complications and morbidity. It is not clear whether there are any predictive factors for incidence or outcomes. Our aim was therefore to record the incidence, presentation, characteristics and progression of paediatric craniopharyngiomas in the West of Scotland.

Method

Retrospective case note review for children diagnosed with paediatric craniopharyngiomas at the Royal Hospital for Children Glasgow, from 1995 to 2021 was conducted. All analyses were conducted using GraphPad Prism 9.4.0.

Results

Of 21 patients diagnosed with craniopharyngiomas, the most common presenting symptoms were headaches (17/21, 81%); visual impairment (13/21, 62%); vomiting (9/21, 43%) and growth failure (7/21, 33%). Seventeen (81%) patients underwent hydrocephalus and/or resection surgery within 3 months of diagnosis, usually within the first 2 weeks (13/21, 62%). Subtotal resection surgeries were performed in 71% of patients, and median time between subsequent resection surgeries for tumour recurrence was 4 years (0,11). BMI SDS increased at 5 year follow-up (p = 0.021) with 43% being obese (BMI > + 2SD). More patients acquired hypopituitarism post-operatively (14/16, 88%) compared to pre-operatively (4/15, 27%). A greater incidence of craniopharyngiomas were reported in more affluent areas (10/21, 48%) (SIMD score 8–10) compared to more deprived areas (6/10, 29%) (SIMD score 1–3). Five patients (24%) died with a median time between diagnosis and death of 9 years (6,13).

Conclusion

Over 25 years the management of craniopharyngioma has changed substantially. Co-morbidities such as obesity are difficult to manage post-operatively and mortality risk can be up to 25% according to our cohort.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:(4)547–551CrossRefPubMed Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:(4)547–551CrossRefPubMed
2.
Zurück zum Zitat Müller HL (2011) Diagnostics, treatment, and follow-up in craniopharyngioma. Front Endocrinol (Lausanne) 2:70CrossRefPubMed Müller HL (2011) Diagnostics, treatment, and follow-up in craniopharyngioma. Front Endocrinol (Lausanne) 2:70CrossRefPubMed
4.
5.
Zurück zum Zitat Tomita T, Bowman RM (2005) Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital. Childs Nerv Syst 21:729–746CrossRefPubMed Tomita T, Bowman RM (2005) Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital. Childs Nerv Syst 21:729–746CrossRefPubMed
6.
Zurück zum Zitat Schubert T, Trippel M, Tacke U, Van Velthoven V, Gumpp V, Bartelt S, Ostertag C, Nikkhah G (2009) Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more? Childs Nerv Syst 25:1419–1427CrossRefPubMed Schubert T, Trippel M, Tacke U, Van Velthoven V, Gumpp V, Bartelt S, Ostertag C, Nikkhah G (2009) Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more? Childs Nerv Syst 25:1419–1427CrossRefPubMed
7.
Zurück zum Zitat Beltran C, Roca M, Merchant TE (2012) On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 82:e281–e287CrossRefPubMed Beltran C, Roca M, Merchant TE (2012) On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 82:e281–e287CrossRefPubMed
8.
Zurück zum Zitat Jimenez RB, Ahmed S, Johnson A, Thomas H, Depauw N, Horick N, Tansky J, Evans CL, Pulsifer M, Ebb D (2021) Proton radiation therapy for pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 110:1480–1487CrossRefPubMed Jimenez RB, Ahmed S, Johnson A, Thomas H, Depauw N, Horick N, Tansky J, Evans CL, Pulsifer M, Ebb D (2021) Proton radiation therapy for pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 110:1480–1487CrossRefPubMed
10.
Zurück zum Zitat Yamada S, Fukuhara N, Oyama K, Takeshita A, Takeuchi Y, Ito J, Inoshita N (2010) Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery. World Neurosurg 74:(2–3)320–330CrossRefPubMed Yamada S, Fukuhara N, Oyama K, Takeshita A, Takeuchi Y, Ito J, Inoshita N (2010) Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery. World Neurosurg 74:(2–3)320–330CrossRefPubMed
12.
Zurück zum Zitat Olsson DS, Andersson E, Bryngelsson IL, Nilsson AG, Johannsson G (2015) Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab 100:(2) 467–474CrossRefPubMed Olsson DS, Andersson E, Bryngelsson IL, Nilsson AG, Johannsson G (2015) Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab 100:(2) 467–474CrossRefPubMed
13.
Zurück zum Zitat Gan HW, Morillon P, Albanese A, Aquilina K, Chandler C, Chang YC, Drimtzias E, Farndon S, Jacques TS, Korbonits M, Kuczynski A, Limond J, Robinson L, Simmons I, Thomas N, Thomas S, Thorp N, Vargha-Khadem F, Warren D, Zebian B, Mallucci C, Spoudeas HA (2023) National UK guidelines for the management of paediatric craniopharyngioma. Lancet Diabetes Endocrinol 11:(9)694–706CrossRefPubMed Gan HW, Morillon P, Albanese A, Aquilina K, Chandler C, Chang YC, Drimtzias E, Farndon S, Jacques TS, Korbonits M, Kuczynski A, Limond J, Robinson L, Simmons I, Thomas N, Thomas S, Thorp N, Vargha-Khadem F, Warren D, Zebian B, Mallucci C, Spoudeas HA (2023) National UK guidelines for the management of paediatric craniopharyngioma. Lancet Diabetes Endocrinol 11:(9)694–706CrossRefPubMed
14.
Zurück zum Zitat Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AM, Müller HL (2015) Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 17:(7) 1029–1038CrossRefPubMedPubMedCentral Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AM, Müller HL (2015) Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 17:(7) 1029–1038CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Karavitaki N, Brufani C, Warner JT, Adams CBT, Richards P, Ansorge O, Shine B, Turner HE, Wass JAH (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol 62:(4) 397–409CrossRef Karavitaki N, Brufani C, Warner JT, Adams CBT, Richards P, Ansorge O, Shine B, Turner HE, Wass JAH (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol 62:(4) 397–409CrossRef
16.
Zurück zum Zitat Kukal K, Dobrovoljac M, Boltshauser E, Ammann RA, Grotzer MA (2009) Does diagnostic delay result in decreased survival in paediatric brain tumours? Eur J Pediatr 168:303–310CrossRefPubMed Kukal K, Dobrovoljac M, Boltshauser E, Ammann RA, Grotzer MA (2009) Does diagnostic delay result in decreased survival in paediatric brain tumours? Eur J Pediatr 168:303–310CrossRefPubMed
17.
Zurück zum Zitat Dobrovoljac M, Hengartner H, Boltshauser E, Grotzer MA (2002) Delay in the diagnosis of paediatric brain tumours. Eur J Pediatr 161:663–667CrossRefPubMed Dobrovoljac M, Hengartner H, Boltshauser E, Grotzer MA (2002) Delay in the diagnosis of paediatric brain tumours. Eur J Pediatr 161:663–667CrossRefPubMed
18.
Zurück zum Zitat Müller H, Gebhardt U, Pohl F, Flentje M, Emser A, Warmuth-Metz M, Kolb R, Calaminus G, Sörensen N (2006) Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma. Klin Padiatr 218:(6)315–320CrossRefPubMed Müller H, Gebhardt U, Pohl F, Flentje M, Emser A, Warmuth-Metz M, Kolb R, Calaminus G, Sörensen N (2006) Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma. Klin Padiatr 218:(6)315–320CrossRefPubMed
19.
Zurück zum Zitat Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ (1993) 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27:(2) 189–195CrossRefPubMed Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ (1993) 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27:(2) 189–195CrossRefPubMed
20.
Zurück zum Zitat Stripp DC, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, Moshang T, Rorke LB, Phillips PC, Sutton LN (2004) Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 58:(3) 714–720CrossRefPubMed Stripp DC, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, Moshang T, Rorke LB, Phillips PC, Sutton LN (2004) Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 58:(3) 714–720CrossRefPubMed
21.
Zurück zum Zitat Müller HL (2008) Childhood craniopharyngioma. Horm Res Paediatr 69:(4) 193–202CrossRef Müller HL (2008) Childhood craniopharyngioma. Horm Res Paediatr 69:(4) 193–202CrossRef
22.
Zurück zum Zitat Vinchon M, Weill J, Delestret I, Dhellemmes P (2009) Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst 25:347–352CrossRefPubMed Vinchon M, Weill J, Delestret I, Dhellemmes P (2009) Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst 25:347–352CrossRefPubMed
23.
Zurück zum Zitat Lustig RH (2011) Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne) 2:60CrossRefPubMed Lustig RH (2011) Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne) 2:60CrossRefPubMed
24.
Zurück zum Zitat Shaikh MG, Grundy RG, Kirk JM (2008) Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity. J Clin Endocrinol Metab 93:(9) 2588–2593CrossRefPubMed Shaikh MG, Grundy RG, Kirk JM (2008) Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity. J Clin Endocrinol Metab 93:(9) 2588–2593CrossRefPubMed
25.
Zurück zum Zitat Harz KJ, Müller HL, Waldeck E, Pudel V, Roth C (2003) Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88:(11) 5227–5231CrossRefPubMed Harz KJ, Müller HL, Waldeck E, Pudel V, Roth C (2003) Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88:(11) 5227–5231CrossRefPubMed
26.
Zurück zum Zitat McKinney P, Ironside J, Harkness E, Arango J, Doyle D, Black R (1994) Registration quality and descriptive epidemiology of childhood brain tumours in Scotland 1975-90. Br J Cancer 70:(5) 973–979CrossRefPubMedPubMedCentral McKinney P, Ironside J, Harkness E, Arango J, Doyle D, Black R (1994) Registration quality and descriptive epidemiology of childhood brain tumours in Scotland 1975-90. Br J Cancer 70:(5) 973–979CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Kehm RD, Spector LG, Poynter JN, Vock DM, Osypuk TL (2018) Socioeconomic status and childhood cancer incidence: a population-based multilevel analysis. Epidemiol Rev 187:(5) 982–991 Kehm RD, Spector LG, Poynter JN, Vock DM, Osypuk TL (2018) Socioeconomic status and childhood cancer incidence: a population-based multilevel analysis. Epidemiol Rev 187:(5) 982–991
28.
Zurück zum Zitat Adel Fahmideh M, Peckham-Gregory EC, Schraw JM, Chintagumpala M, Mack SC, Lupo PJ, Scheurer ME (2021) Maternal and perinatal factors are associated with risk of pediatric central nervous system tumors and poorer survival after diagnosis. Sci Rep 11:(1) 10410CrossRefPubMedPubMedCentral Adel Fahmideh M, Peckham-Gregory EC, Schraw JM, Chintagumpala M, Mack SC, Lupo PJ, Scheurer ME (2021) Maternal and perinatal factors are associated with risk of pediatric central nervous system tumors and poorer survival after diagnosis. Sci Rep 11:(1) 10410CrossRefPubMedPubMedCentral
Metadaten
Titel
Presentation and outcomes of paediatric craniopharyngioma in the west of Scotland: a 25 year experience
verfasst von
Xuan Ye Chanel Kuah
Angela K. Lucas-Herald
Sarah McCarrison
Roisin Boyle
Claire Adey
Anthony Amato-Watkins
Parameswaran Bhattathiri
Emer Campbell
Fiona Cowie
Liam Dorris
Ben Fulton
Diana Mcintosh
Dermot Murphy
Milind Ronghe
Roddy O’Kane
Lorraine Todd
Meharpal Sangra
Jairam Sastry
Eoghan Millar
Samih Hassan
M. Guftar Shaikh
Publikationsdatum
15.01.2024
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2024
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-023-04490-5

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

Kaum Vorteile durch intraarterielle Lyse während Thrombektomie

Nach der Thrombektomie kleinere Fragmente über eine intraarterielle Lyse auflösen – dies könnte die Schlaganfalltherapie verbessern. Zwei aktuelle Studien ergeben für die periprozedurale Lyse jedoch keine großen Vorteile. Die Frage, wie viel sie nützt, bleibt weiter offen.

Nasenstimulation lindert chronische Migräne

Wird die Naseninnenseite durch Vibrationen stimuliert, kann dies offenbar die Zahl der Migränetage von Menschen mit chronischer Migräne deutlich senken. Darauf deuten die Resultate einer randomisiert-kontrollierten deutsch-finnischen Untersuchung.

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.